| Charles V Mullen Jr, MD | |
|
3 Saint Francis Dr, Suite 300, Greenville, SC 29601-3971 | |
| (864) 233-8063 | |
| Not Available |
| Full Name | Charles V Mullen Jr |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 46 Years |
| Location | 3 Saint Francis Dr, Greenville, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447358478 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 9455 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Francis-downtown | Greenville, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bon Secours Medical Group Greenville Specialty Care Llc | 1850779976 | 231 |
News Archive
Genzyme Corporation announced today that it will reopen enrollment in the Alglucosidase Alfa Temporary Access Program (ATAP), a program which provides access to treatment for severely affected adults with Pompe disease prior to commercial approval of Lumizyme™ (alglucosidase alfa). Genzyme and the FDA have also agreed on a path toward approval of Lumizyme.
Politico reports on how the elections of 2012 will dictate the future of the health law. Also, other news outlets report on states' efforts to figure out what to do if the individual mandate is struck down, the essential benefits package, the development of health exchanges and where things stand with accountable care organizations.
A new report, published in Perspectives in Health Information Management, by The George Washington University School of Public Health and Health Services Department of Health Policy, examines the feasibility of using the Medicaid Statistical Information System, an existing data source, to fulfill some of the requirements outlined in section 401 of the Children's Health Insurance Program Reauthorization Act of 2009.
Aggression, violence, depression, suicide. Media reports routinely link these behavioral symptoms with chronic traumatic encephalopathy (CTE), the neurodegenerative brain disease, in former football players.
› Verified 6 days ago
| Entity Name | St Francis Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558305995 PECOS PAC ID: 3779487186 Enrollment ID: O20031126000091 |
News Archive
Genzyme Corporation announced today that it will reopen enrollment in the Alglucosidase Alfa Temporary Access Program (ATAP), a program which provides access to treatment for severely affected adults with Pompe disease prior to commercial approval of Lumizyme™ (alglucosidase alfa). Genzyme and the FDA have also agreed on a path toward approval of Lumizyme.
Politico reports on how the elections of 2012 will dictate the future of the health law. Also, other news outlets report on states' efforts to figure out what to do if the individual mandate is struck down, the essential benefits package, the development of health exchanges and where things stand with accountable care organizations.
A new report, published in Perspectives in Health Information Management, by The George Washington University School of Public Health and Health Services Department of Health Policy, examines the feasibility of using the Medicaid Statistical Information System, an existing data source, to fulfill some of the requirements outlined in section 401 of the Children's Health Insurance Program Reauthorization Act of 2009.
Aggression, violence, depression, suicide. Media reports routinely link these behavioral symptoms with chronic traumatic encephalopathy (CTE), the neurodegenerative brain disease, in former football players.
› Verified 6 days ago
| Entity Name | St Francis Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457057622 PECOS PAC ID: 6608826821 Enrollment ID: O20050126000259 |
News Archive
Genzyme Corporation announced today that it will reopen enrollment in the Alglucosidase Alfa Temporary Access Program (ATAP), a program which provides access to treatment for severely affected adults with Pompe disease prior to commercial approval of Lumizyme™ (alglucosidase alfa). Genzyme and the FDA have also agreed on a path toward approval of Lumizyme.
Politico reports on how the elections of 2012 will dictate the future of the health law. Also, other news outlets report on states' efforts to figure out what to do if the individual mandate is struck down, the essential benefits package, the development of health exchanges and where things stand with accountable care organizations.
A new report, published in Perspectives in Health Information Management, by The George Washington University School of Public Health and Health Services Department of Health Policy, examines the feasibility of using the Medicaid Statistical Information System, an existing data source, to fulfill some of the requirements outlined in section 401 of the Children's Health Insurance Program Reauthorization Act of 2009.
Aggression, violence, depression, suicide. Media reports routinely link these behavioral symptoms with chronic traumatic encephalopathy (CTE), the neurodegenerative brain disease, in former football players.
› Verified 6 days ago
| Entity Name | Bon Secours Medical Group Greenville Specialty Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821679580 PECOS PAC ID: 1850779976 Enrollment ID: O20220602000070 |
News Archive
Genzyme Corporation announced today that it will reopen enrollment in the Alglucosidase Alfa Temporary Access Program (ATAP), a program which provides access to treatment for severely affected adults with Pompe disease prior to commercial approval of Lumizyme™ (alglucosidase alfa). Genzyme and the FDA have also agreed on a path toward approval of Lumizyme.
Politico reports on how the elections of 2012 will dictate the future of the health law. Also, other news outlets report on states' efforts to figure out what to do if the individual mandate is struck down, the essential benefits package, the development of health exchanges and where things stand with accountable care organizations.
A new report, published in Perspectives in Health Information Management, by The George Washington University School of Public Health and Health Services Department of Health Policy, examines the feasibility of using the Medicaid Statistical Information System, an existing data source, to fulfill some of the requirements outlined in section 401 of the Children's Health Insurance Program Reauthorization Act of 2009.
Aggression, violence, depression, suicide. Media reports routinely link these behavioral symptoms with chronic traumatic encephalopathy (CTE), the neurodegenerative brain disease, in former football players.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles V Mullen Jr, MD 3 Saint Francis Dr, Suite 300, Greenville, SC 29601-3971 Ph: (864) 233-8063 | Charles V Mullen Jr, MD 3 Saint Francis Dr, Suite 300, Greenville, SC 29601-3971 Ph: (864) 233-8063 |
News Archive
Genzyme Corporation announced today that it will reopen enrollment in the Alglucosidase Alfa Temporary Access Program (ATAP), a program which provides access to treatment for severely affected adults with Pompe disease prior to commercial approval of Lumizyme™ (alglucosidase alfa). Genzyme and the FDA have also agreed on a path toward approval of Lumizyme.
Politico reports on how the elections of 2012 will dictate the future of the health law. Also, other news outlets report on states' efforts to figure out what to do if the individual mandate is struck down, the essential benefits package, the development of health exchanges and where things stand with accountable care organizations.
A new report, published in Perspectives in Health Information Management, by The George Washington University School of Public Health and Health Services Department of Health Policy, examines the feasibility of using the Medicaid Statistical Information System, an existing data source, to fulfill some of the requirements outlined in section 401 of the Children's Health Insurance Program Reauthorization Act of 2009.
Aggression, violence, depression, suicide. Media reports routinely link these behavioral symptoms with chronic traumatic encephalopathy (CTE), the neurodegenerative brain disease, in former football players.
› Verified 6 days ago
Abdullah Darvesh, Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 701 Grove Rd, Greenville, SC 29605 Phone: 864-455-7882 | |
Daniel Ruiz, Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 701 Grove Rd, Greenville, SC 29605 Phone: 864-455-7882 | |
Rhett Mckey Shirley, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 890 W Faris Rd, Suite 520, Greenville, SC 29605 Phone: 864-455-9033 Fax: 864-455-6559 | |
Mohammad Rashid, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 61 Pointe Cir, Greenville, SC 29615 Phone: 864-286-6960 Fax: 864-286-8710 | |
Benjamin Ellis Rawls, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Grove Rd Fl 5, Greenville, SC 29605 Phone: 864-455-4411 | |
Alan Robert Thompson, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Grove Rd, 5th Floor, Greenville, SC 29605 Phone: 864-455-4411 Fax: 864-455-4480 | |
Caroline Dillard Brownlee, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1025 Verdae Blvd, Suite A, Greenville, SC 29607 Phone: 864-242-4683 Fax: 864-240-8104 |